Showing results (401-410 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Combining zip code-based population data and pharmacy administrative claims data to create measures of social determinants of healthBrooke D Hunter, Kristin D Brown-Gentry, Mark A Santilli, et al.Journal of Managed Care & Specialty Pharmacy|March 31, 2024
Geographic disparity in the distribution of cancer clinical trials in the United States and the associated factorsNingzhou Gu, Zizi Elsisi, Ryan Suk, et al.Journal of Managed Care & Specialty Pharmacy|January 26, 2024
Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolismDionne M Hines, Riddhi Doshi, Vamshi Ruthwik Anupindi, et al.Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Estimated discounts generated by Medicare drug negotiation in 2026Inmaculada Hernandez, Nico Gabriel, Sean DicksonJournal of Managed Care & Specialty Pharmacy|July 31, 2023
Cost sharing in managed care and the ethical question of business purposeRobert C HughesJournal of Managed Care & Specialty Pharmacy|July 31, 2023
Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United StatesLuis Hernandez-Pastor, Jeroen Geurtsen, Bryan Baugh, et al.Journal of Managed Care & Specialty Pharmacy|March 26, 2026
The impact of data source on real-world medication adherence and exposure measures: From prescription to soldYifan Zheng, Karen B Farris, Antoinette B Coe, et al.Journal of Managed Care & Specialty Pharmacy|April 23, 2024
A primer on brand-name prescription drug contractingJames T Kenney, Shellie KeastJournal of Managed Care & Specialty Pharmacy|April 16, 2024
Assessing health plan payer's budget impact of etranacogene dezaparvovec for the treatment of hemophilia B in the United StatesMichele Wilson, Cheryl McDade, Kris Thiruvillakkat, et al.Journal of Managed Care & Specialty Pharmacy|May 8, 2024
Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United StatesLisa Kennedy, Ernie Lee, Ronald Flauto, et al.Pageof 185